Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. 1994

K A Reimann, and K Tenner-Racz, and P Racz, and D C Montefiori, and Y Yasutomi, and W Lin, and B J Ransil, and N L Letvin
New England Regional Primate Research Center, Harvard Medical School, Southborough, Massachusetts 01772.

Infection of the rhesus monkey with simian immunodeficiency virus of macaques (SIVmax) was employed to explore the early immune events associated with the initial containment of an acute AIDS virus infection. In nine rhesus monkeys infected intravenously with uncloned SIVmac strain 251, high-level p27 plasma antigenemia was usually detected transiently from approximately day 7 through day 21 following virus inoculation. SIVmac replication in lymph nodes measured by in situ RNA hybridization closely paralleled the time course and magnitude of viremia. The containment of SIVmac spread by 3 to 4 weeks following infection suggests an efficient, early immune control of this virus infection. Anti-SIVmac antibodies were first detected in the blood at approximately day 14. At the time antigenemia was decreased or cleared, SIVmac neutralizing antibodies were present. A rise in circulating and lymph node CD8+ T cells also occurred coincident with the clearance of antigenemia and persisted thereafter. These CD8+ lymphocytes in lymph nodes had increased expression of both major histocompatibility complex class II and the adhesion molecule LFA-1; they also demonstrated decreased expression of the naive T-cell-associated CD45RA molecule. SIVmac-specific cytotoxic T-lymphocyte precursors were detected in both blood and lymph node by 7 days post-virus inoculation. These studies indicate that both virus-specific humoral and cellular immune mechanisms in blood and lymph node are associated with the clearance of viremia that occurs within the first month of infection of rhesus monkeys with SIVmac.

UI MeSH Term Description Entries
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008218 Lymphocytosis Excess of normal lymphocytes in the blood or in any effusion. Lymphocytoses
D008251 Macaca A genus of the subfamily CERCOPITHECINAE, family CERCOPITHECIDAE, consisting of 16 species inhabiting forests of Africa, Asia, and the islands of Borneo, Philippines, and Celebes. Ape, Barbary,Ape, Black,Ape, Celebes,Barbary Ape,Black Ape,Celebes Ape,Macaque,Apes, Barbary,Apes, Black,Apes, Celebes,Barbary Apes,Black Apes,Celebes Apes,Macacas,Macaques
D008253 Macaca mulatta A species of the genus MACACA inhabiting India, China, and other parts of Asia. The species is used extensively in biomedical research and adapts very well to living with humans. Chinese Rhesus Macaques,Macaca mulatta lasiota,Monkey, Rhesus,Rhesus Monkey,Rhesus Macaque,Chinese Rhesus Macaque,Macaca mulatta lasiotas,Macaque, Rhesus,Rhesus Macaque, Chinese,Rhesus Macaques,Rhesus Macaques, Chinese,Rhesus Monkeys
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D013602 T-Lymphocytes, Cytotoxic Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These CD8-positive cells are distinct from NATURAL KILLER CELLS and NATURAL KILLER T-CELLS. There are two effector phenotypes: TC1 and TC2. Cell-Mediated Lympholytic Cells,Cytotoxic T Cells,Cytotoxic T Lymphocyte,Cytotoxic T-Lymphocytes,TC1 Cell,TC1 Cells,TC2 Cell,TC2 Cells,Cell Mediated Lympholytic Cells,Cell, Cell-Mediated Lympholytic,Cell, TC1,Cell, TC2,Cell-Mediated Lympholytic Cell,Cytotoxic T Cell,Cytotoxic T Lymphocytes,Cytotoxic T-Lymphocyte,Lymphocyte, Cytotoxic T,Lympholytic Cell, Cell-Mediated,Lympholytic Cells, Cell-Mediated,T Cell, Cytotoxic,T Lymphocyte, Cytotoxic,T Lymphocytes, Cytotoxic,T-Lymphocyte, Cytotoxic

Related Publications

K A Reimann, and K Tenner-Racz, and P Racz, and D C Montefiori, and Y Yasutomi, and W Lin, and B J Ransil, and N L Letvin
January 1990, Journal of acquired immune deficiency syndromes,
K A Reimann, and K Tenner-Racz, and P Racz, and D C Montefiori, and Y Yasutomi, and W Lin, and B J Ransil, and N L Letvin
November 1990, AIDS research and human retroviruses,
K A Reimann, and K Tenner-Racz, and P Racz, and D C Montefiori, and Y Yasutomi, and W Lin, and B J Ransil, and N L Letvin
August 2000, Journal of medical primatology,
K A Reimann, and K Tenner-Racz, and P Racz, and D C Montefiori, and Y Yasutomi, and W Lin, and B J Ransil, and N L Letvin
November 2015, Journal of neuropathology and experimental neurology,
K A Reimann, and K Tenner-Racz, and P Racz, and D C Montefiori, and Y Yasutomi, and W Lin, and B J Ransil, and N L Letvin
October 1992, The Journal of infectious diseases,
K A Reimann, and K Tenner-Racz, and P Racz, and D C Montefiori, and Y Yasutomi, and W Lin, and B J Ransil, and N L Letvin
January 1989, Nature,
K A Reimann, and K Tenner-Racz, and P Racz, and D C Montefiori, and Y Yasutomi, and W Lin, and B J Ransil, and N L Letvin
September 2010, Journal of proteome research,
K A Reimann, and K Tenner-Racz, and P Racz, and D C Montefiori, and Y Yasutomi, and W Lin, and B J Ransil, and N L Letvin
December 2019, mBio,
K A Reimann, and K Tenner-Racz, and P Racz, and D C Montefiori, and Y Yasutomi, and W Lin, and B J Ransil, and N L Letvin
January 1989, Journal of medical primatology,
K A Reimann, and K Tenner-Racz, and P Racz, and D C Montefiori, and Y Yasutomi, and W Lin, and B J Ransil, and N L Letvin
February 1993, Journal of virology,
Copied contents to your clipboard!